Candel Therapeutics, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Candel Therapeutics, Inc. | CADL - NASDAQ |
$8.00-$8.00 | $8.00 | $8.00 | 9 million | 7/27/2021 |
| Jefferies, Credit Suisse, BMO Capital Markets, UBS Investment Bank | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2021-06-25 Terms Added 2021-07-16 Terms Changed 2021-07-26 | ||||||
Candel Therapeutics, Inc. Quote & Chart - Click for current quote - CADL
IPO Boutique aggregates information on public companies and private companies, such as "CADL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Candel Therapeutics, Inc. (adapted from Candel Therapeutics, Inc. prospectus):
They are a late clinical stage biopharmaceutical company focused on helping patients fight cancer with oncolytic viral immunotherapies.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a late clinical stage biopharmaceutical company focused on helping patients fight cancer with oncolytic viral immunotherapies.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "CADL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.